Podcasts about veterinary medicine cvm

Send us a textDr. Tristan Colonius, DVM is the Chief Veterinary Officer and Deputy Director for Science Policy at FDA's Center for Veterinary Medicine ( CVM - https://www.fda.gov/animal-veterinary ). Dr. Colonius previously worked in various positions at FDA, including as Deputy Chief of Staff to Commissioner Dr. Robert Califf and as an International Policy Analyst. During his career at FDA, Dr. Colonius has been working on numerous initiatives including the Animal and Veterinary Innovation Agenda, One Health, Intentional Genomic Alterations in animals,  and zootechnical animal feed substances (ZAFS) among many other programs at CVM.Prior to joining FDA, Dr. Colonius held positions in the US Senate and US Department of Agriculture. Dr.  Colonius came to the Hill as an American Association for the Advancement of Science (AAAS) Science and Technology fellow in 2012 in Senator Kirsten Gillibrand's (NY) office and worked to help pass the Agricultural Act of 2014 (the “Farm Bill”) renewal. Dr. Colonius then went to work for Senator Diane Feinstein, first as a Legislative Assistant and then as her Deputy Legislative Director. While in Senator Feinstein's office, Dr. Colonius worked on disaster preparedness, climate resiliency, emerging public health threats, homeland security, federal science policy, and animal welfare/conservation.Dr. Colonius holds a BA in Political Science and Doctor of Veterinary Medicine from Louisiana State University, as well as a Master of Public Administration from the University of Illinois.Important Episode LinkThe Animal and Veterinary Innovation Agenda - Center for Veterinary Medicine (CVM) - FDA - https://www.fda.gov/news-events/press-announcements/fda-supports-innovation-animal-biotechnology-veterinary-products-food-animals-through-new#FoodAndDrugAdministration #FDA #CenterForVeterinaryMedicine #OneHealth #TristanColonius #AnimalWelfare #PetMedicine #ConditionalApproval #SciencePolicy #AntimicrobialResistance #Zoonotic #Zoooses #GMO #RobertCaliff #KirstenGillibrand #DianeFeinstein  #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Kimberly Dodd is the new dean of Michigan State University's College of Veterinary Medicine (CVM). Dean Dodd talks about research and practice strengths of the college and shares some of her short- and long-term goals for CVM. And she describes challenges and opportunities ahead for the college and higher education. Conversation Highlights: (0:21) – How long have you been at MSU, and what first attracted you here? (2:01) – Tell us more about MSU's Veterinary Diagnostic Laboratory (VDL). (3:08) – How, when and why did MSU become a veterinary powerhouse? (4:32) – What are some of the research and practice interests? (5:39) – Why do you want to be dean of the college? (6:33) – What are some of your short- and long-term goals for the college? (7:23) – What are some of the challenges and opportunities ahead for the college? (8:06) – What are your thoughts on the future of higher education? (8:48) – What's the job market like for your graduates? Listen to “MSU Today with Russ White” on the radio and through Spotify, Apple Podcasts, and wherever you get your shows.

Do you feel like you can't afford your horse? You're not alone. Understand how to manage horse expenses to lessen the stress of horse keeping. The cost of horse ownership varies from region to region, but even basic expenses such as feed, bedding, and routine veterinary and farrier care can be very costly. Emergency veterinary expenses can soar depending on the illness or injury. Preparing for routine expenses and potential emergencies by budgeting can help horse owners obtain financial security for costs associated with horse ownership. In this episode of Ask TheHorse Live, two experts join us to answer common questions about budgeting and planning for horse expenses.This podcast is brought to you by CareCredit. About the Experts: Jorge L. Colón, DVM, MBA, is an associate professor of practice in financial and organizational management at the Cornell University College of Veterinary Medicine (CVM), in Ithaca, New York, and serves as the director of business education for the Cornell Center for Veterinary Business and Entrepreneurship. He received his BS and DVM from Cornell and his MBA from the College of Business at Colorado State University, in Fort Collins. Colón spent the first 25 years of his professional veterinary career as an equine ambulatory veterinarian in Lexington, Kentucky, concentrating in the areas of equine reproduction, neonatology, radiology, and Thoroughbred sales. He transitioned into academia in 2020, where he is now tasked with the development and implementation of the veterinary business educational curriculum at the Cornell CVM and with the management and administration of the Cornell CVBE Certificate in Veterinary Business and Management.Wendy Krebs, DVM, is a partner at Bend Equine Medical Center in Bend, Oregon. She grew up in Western Oregon, where she participated first in 4-H and later in eventing. She graduated from Oregon State University College of Veterinary Medicine, in Corvallis, in 2002 and performed a yearlong equine internship, followed by a four-year American College of Veterinary Surgeons equine surgery residency. Her practice interests include surgery and performance horse care, as well as comprehensive preventive care. She lives on a small working ranch in Tumalo with her husband, two young children, and a bevy of animals, including nine horses. She enjoys riding her Oldenburg mare, Aria, emergency-schedule permitting.

Donald A. Prater, D.V.M. is Acting Director of the Office of Food Policy and Response (OFPR) at the U.S. Food and Drug Administration. Since 2019, he has also served as Associate Commissioner for Imported Food Safety in OFPR, providing direction to and management of imported food safety programs. In addition, he served as a senior scientific advisor and technical expert on matters related to human and animal food safety and the implementation of the FDA Food Safety Modernization Act (FSMA). Before joining OFPR, Dr. Prater was the Assistant Commissioner for Food Safety Integration, serving as the principal spokesperson on behalf of FDA's Foods and Veterinary Medicine Program for imports discussions with external stakeholders, including foreign governments, as well as being responsible for import-related strategic resource planning activities. Earlier in his FDA tenure, Dr. Prater was Director of FDA's Europe Office in Brussels, Belgium, and served as the U.S. Department of Health and Human Services (HHS) Country Representative to the EU. Dr. Prater received a Doctor of Veterinary Medicine from the Virginia-Maryland Regional College of Veterinary Medicine (Government and Corporate track) in 1996. Following a three-year residency in anatomic pathology, he joined FDA's Center for Veterinary Medicine (CVM) in 1999 as a Veterinary Medical Officer. He served in several roles including Leader of the Aquaculture Drugs Team, CVM Pathologist, and Director of the Division of Scientific Support. In this episode of Food Safety Matters, we speak with Dr. Prater [28:44] about: FDA initiatives and FSMA standards that address some of the food safety risks posed by global supply chain disruptions Activities FDA is undertaking to ensure the safety of imported produce, in alignment with the 2019 Strategy for the Safety of Imported Food How FDA's commodity-specific prevention strategies increase food safety by engaging industry and leveraging lessons learned from outbreaks The reasoning behind FDA's 2022 literature review on food safety culture, and how findings on the emerging discipline are applicable to FDA and industry How FDA collaborated with Stop Foodborne Illness to further Core Element 4—Food Safety Culture—under the New Era of Smarter Food Safety blueprint, which will be discussed in an upcoming FDA/Stop Foodborne Illness webinar live from the Food Safety Summit on May 11 Initiatives FDA is taking to improve its understanding of food safety culture and educate stakeholders Dr. Prater's outlook on how the proposed reorganization of FDA's Human Foods program may affect the agency's emphasis on food safety culture Efforts FDA is making in the area of consumer food safety education through the lens of the New Era of Smarter Food Safety Why “better food safety in the 21st Century begins and ends with better data,” and the technologies that are enabling improved collection, analysis, and quality of data Industry privacy concerns amid an increasingly digitalized and traceable food system. News and ResourcesDr. Susan Mayne to Resign as Director of FDA's CFSAN [6:45] FDA Releases Strategy to Increase Resilience of U.S. Infant Formula Market; Officials Express Uncertainty in House Subcommittee Hearing [9:16]Bill Introduced in California Would Ban Five Toxic Chemicals Common in Processed Foods [20:11]CDC Identifies Non-Typhoidal Salmonella as Major Pathogen Causing Foodborne Illness in U.S., Ground Beef Common Cause [23:26]SMU Researcher Develops Mini pH Sensor that Indicates Food Spoilage in Real Time [25:31] FDA/Stop Foodborne Illness Webinar on May 11 Register here! Food Safety Summit 2023Register for the 2023 Food Safety Summit with discount code FSM23Podcast for 10% off! We Want to Hear from You! Please send us your questions and suggestions to podcast@food-safety.com

On this week's The Sci-Files, your hosts Chelsie and Danny interview Bridget Walker. Bridget is a third-year student in the College of Veterinary Medicine (CVM) at MSU. She began working at the Potter Park Zoo as a summer student under Dr. Ronan Eustace, the staff veterinarian and Director of Animal Health at Potter Park Zoo (PPZ), where she conducted a research project and zoo medical cases. She has been featured on The Sci-Files before for her research at PPZ with Doppsee, but this episode focuses on her research with the Red Pandas at PPZ.Thyroid dysfunction has been reported in captive red pandas, however, there has been little research on the topic. The research project Bridget worked on validates a hormone test in red pandas that measure thyroid-stimulating hormones and can help to identify thyroid dysfunction. By having a valid test, thyroid dysfunction can be identified and further studied in red pandas. To find out more about PPZ, ways that you can support the red pandas and the other animals at PPZ, you can visit their website.If you're interested in talking about your MSU research on the radio or nominating a student, please email Chelsie and Danny at scifiles@impact89fm.org. You can ask questions for our future episodes here. Check The Sci-Files out on Twitter, Facebook, Instagram, and YouTube!

This week on The Sci-Files, Chelsie and Danny went to Potter Park Zoo to see Doppsee, the pregnant black rhino, get an ultrasound. While they were there, they interviewed a variety of people who interact with Doppsee and have experience in veterinary medicine. In this interview, you will hear the perspectives and knowledge of 9 different interviewees.Doppsee is the 13-year-old female eastern black rhino at Potter Park Zoo, who is originally from Sedgwick County Zoo in Kansas. The male rhino at Potter Park, Phineus, traveled to Lansing from Caldwell Zoo in Texas in 2017.Before the ultrasound, Chelsie and Danny discussed Doppsee's pregnancy with students in their fourth year at the College of Veterinary Medicine (CVM) at Michigan State University (MSU): Bethany Myers, Peter Fowler, Sumana Prabhakar, and Ashleigh Shoemaker.Chelsie and Danny also spoke to Bridget Walker, a third-year student in the CVM at MSU. She began working at the Potter Park Zoo as a summer student under Dr. Ronan Eustace, the staff veterinarian and Director of Animal Health at Potter Park Zoo. She conducted a research project and zoo medical cases, which allowed her to visit Doppsee and monitor her pregnancy.After viewing Doppsee's ultrasound, Chelsie and Danny spoke to the vets who conducted the ultrasound and the Potter Park Zoo Animal Care Supervisor.Dr. Julie Strachota is a clinical instructor for the Department of Large Animal Clinical Sciences and resident for the Large Animal Theriogenology Service. She is an MSU native with a Bachelor of Science (B.S.) in Animal Science, Master of Science in Large Animal Clinical Sciences, and a Doctorate of Veterinary Medicine from MSU. Before returning to MSU as an instructor, Dr. Strachota worked for four years in a progressive, equine-exclusive practice, which is where she developed a strong interest and skill set in equine reproductive techniques. Besides her passion for theriogenology (a branch of veterinary medicine focusing on reproduction), Dr. Strachota is developing an equine primary care service for clinical veterinary students.Dr. Carleton is a graduate of the Kansas State University CVM. She was the equine theriogenologist at MSU's CVM for more than 30 years. In addition to her decades of dedication to theriogenology, she served for years on the exam committee as president of the American College of Theriogenologists and founded Diplomate of the American College of Animal Welfare. Both specialties are AVMA recognized. Dr. Carleton continues her work globally.Dr. Ronan Eustace has a Doctorate of Veterinary Medicine from the University of Saskatchewan, Western CVM. After three and a half years at Potawatomi Zoo, Dr. Ronan Eustace came to Potter Park Zoo. Before coming to Potter Park Zoo, Dr. Ronan worked at practices ranging from sizeable multi-doctor specialty practices to small rural mixed clinics for four years before he became a zoo veterinarian.Pat Fountain is the Animal Care Supervisor at Potter Park Zoo. He received his B.S. in Zoology in 2006 from Michigan State University. Pat has cared for Doppsee since she arrived in 2011. Pat said, “Soon after arriving, it was apparent she [Doppsee] was a special rhino, and we have formed an incredible bond over the last eight years.”“Doppsee is almost always willing to train and has helped us accomplish much more in her time here than we ever thought possible. We are eagerly anticipating the birth of her first calf, and we are hopeful she is going to be a great mother.”To find out more about Potter Park Zoo, ways that you can support Doppsee's pregnancy and the other animals at Potter Park Zoo, you can visit their website.If you're interested in talking about your MSU research on the radio or nominating a student, please email Chelsie and Danny at scifiles@impact89fm.org. Check The Sci-Files out on Twitter @SciFiles89FM and Facebook!

Grain-free dog food—particularly products containing high levels of potatoes, pulses, or legumes like lentils and peas—is under fire as FDA’s Center for Veterinary Medicine (CVM) investigates a potential connection between canine diet and a heart disease known as dilated cardiomyopathy (DCM). Holistic veterinarian Chris Bessent shares details such as the affected breeds and pet food companies; hazards of modeling animal nutrition after human food trends; suggestions for dog food manufacturers to mitigate risk and boost transparency; and a possible link between glyphosate (an herbicide used in farming), grain-free foods and cardiac issues.

In this episode Dr. McFaddin explains the FDA Center for Veterinary Medicine (CVM) announcements released in September (Possible Link Between Oral Flea and Tick Preventatives and Seizures in Dogs) and in July (Possible Link Between Grain Free Diets and Heart Disease in Dogs). For further information about the FDA CVM Announcements visit their website or sign up for the email alerts when new releases are issued: https://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/default.htm.

On September 18, 2008 at the Koshland Science Museum in Washington, D.C., Dr. Stuart Levy, professor of Molecular Biology and Microbiology at Tufts University School of Medicine and Dr. Linda Tollefson, Assistant Commissioner for Science at the U.S. Food and Drug Administration, discussed how to optimize antibiotic use and how to minimize the emergence of drug resistant pathogens. In part 2 of this 3 part video series, Dr. Levy discusses how antibiotic resistance develops, the development practices drug companies employ when producing antimicrobials, and how this process may change in the future. Dr. Tollefson outlines how the FDA is encouraging the development of antibiotics in an industry that is mostly focussed on manufacturing drugs for chronic illnesses. Dr. Levy is Professor of Molecular Biology and Microbiology at Tufts University School of Medicine where he is the Director of the Center for Adaptation Genetics and Drug Resistance. He directs research on mechanisms of bacterial antibiotic resistance. Stuart Levy is also Staff Physician at the Tufts Medical Center and he also serves as the president of The International Alliance for the Prudent Use of Antibiotics. Dr. Tollefson is Assistant Commissioner for Science at the U.S. Food and Drug Administration (FDA). She previously served as Deputy Director of the Center for Veterinary Medicine (CVM), where she led CVM's efforts to implement a risk-based approach to address antimicrobial resistance, fulfilling a 2001 Congressional mandate, and was instrumental in the founding of the National Antimicrobial Resistance Monitoring System for Enteric Bacteria. Tollefson also served as Chief of Epidemiology in the Center for Food Safety and Applied Nutrition where she successfully investigated numerous outbreaks of food borne disease and served as liaison to the Centers for Disease Control and Prevention.

On September 18, 2008 at the Koshland Science Museum in Washington, D.C., Dr. Stuart Levy, professor of Molecular Biology and Microbiology at Tufts University School of Medicine and Dr. Linda Tollefson, Assistant Commissioner for Science at the U.S. Food and Drug Administration, discussed how to optimize antibiotic use and how to minimize the emergence of drug resistant pathogens. In part 2 of this 3 part video series, Dr. Levy discusses how antibiotic resistance develops, the development practices drug companies employ when producing antimicrobials, and how this process may change in the future. Dr. Tollefson outlines how the FDA is encouraging the development of antibiotics in an industry that is mostly focused on manufacturing drugs for chronic illnesses. Dr. Levy is Professor of Molecular Biology and Microbiology at Tufts University School of Medicine where he is the Director of the Center for Adaptation Genetics and Drug Resistance. He directs research on mechanisms of bacterial antibiotic resistance. Stuart Levy is also Staff Physician at the Tufts Medical Center and he also serves as the president of The International Alliance for the Prudent Use of Antibiotics. Dr. Tollefson is Assistant Commissioner for Science at the U.S. Food and Drug Administration (FDA). She previously served as Deputy Director of the Center for Veterinary Medicine (CVM), where she led CVM's efforts to implement a risk-based approach to address antimicrobial resistance, fulfilling a 2001 Congressional mandate, and was instrumental in the founding of the National Antimicrobial Resistance Monitoring System for Enteric Bacteria. Tollefson also served as Chief of Epidemiology in the Center for Food Safety and Applied Nutrition where she successfully investigated numerous outbreaks of food borne disease and served as liaison to the Centers for Disease Control and Prevention. Part 3 will be published next week.

On September 18, 2008 at the Koshland Science Museum in Washington, D.C., Dr. Stuart Levy, professor of Molecular Biology and Microbiology at Tufts University School of Medicine and Dr. Linda Tollefson, Assistant Commissioner for Science at the U.S. Food and Drug Administration, discussed how to optimize antibiotic use and how to minimize the emergence of drug resistant pathogens. In part 2 of this 3 part video series, Dr. Levy discusses how antibiotic resistance develops, the development practices drug companies employ when producing antimicrobials, and how this process may change in the future. Dr. Tollefson outlines how the FDA is encouraging the development of antibiotics in an industry that is mostly focussed on manufacturing drugs for chronic illnesses. Dr. Levy is Professor of Molecular Biology and Microbiology at Tufts University School of Medicine where he is the Director of the Center for Adaptation Genetics and Drug Resistance. He directs research on mechanisms of bacterial antibiotic resistance. Stuart Levy is also Staff Physician at the Tufts Medical Center and he also serves as the president of The International Alliance for the Prudent Use of Antibiotics. Dr. Tollefson is Assistant Commissioner for Science at the U.S. Food and Drug Administration (FDA). She previously served as Deputy Director of the Center for Veterinary Medicine (CVM), where she led CVM's efforts to implement a risk-based approach to address antimicrobial resistance, fulfilling a 2001 Congressional mandate, and was instrumental in the founding of the National Antimicrobial Resistance Monitoring System for Enteric Bacteria. Tollefson also served as Chief of Epidemiology in the Center for Food Safety and Applied Nutrition where she successfully investigated numerous outbreaks of food borne disease and served as liaison to the Centers for Disease Control and Prevention.

Will we become defenseless against bacteria? Will bacteria always find a way to infect and even kill us? The emergence of antibiotic resistant strains of bacteria poses an enormous problem around the world. Scientists believe that the overuse of antibiotics is increasing the appearance of these pathogens. In the US, increasing casualties resulting from drug resistant staphylococcus infections received wide media attention. While antibiotics only work on bacterial infections, many patients and doctors regard antibiotics as a front-line form of treating any type of infection. Antibiotics are often prescribed because the specific pathogen that is causing an illness is often difficult to determine. In some cases they are used as a preventative measure. But is this the best defense? Are there ways to beat bacteria at their own game? On September 18, 2008 at the Koshland Science Museum in Washington, D.C., Dr. Stuart Levy, professor of Molecular Biology and Microbiology at Tufts University School of Medicine and Dr. Linda Tollefson, Assistant Commissioner for Science at the U.S. Food and Drug Administration, discussed how to optimize antibiotic use and how to minimize the emergence of drug resistant pathogens. In part 1 of this 3 part video series, Dr. Levy discusses the basics of microbial pathogens, bacteria, and antibiotic resistance. And, Dr. Tollefson outlines the various types and classes of antibiotic drugs, approved uses, and current levels of effectiveness. Dr. Levy is Professor of Molecular Biology and Microbiology at Tufts University School of Medicine where he is the Director of the Center for Adaptation Genetics and Drug Resistance. He directs research on mechanisms of bacterial antibiotic resistance. Stuart Levy is also Staff Physician at the Tufts Medical Center and he also serves as the president of The International Alliance for the Prudent Use of Antibiotics. Dr. Tollefson is Assistant Commissioner for Science at the U.S. Food and Drug Administration (FDA). She previously served as Deputy Director of the Center for Veterinary Medicine (CVM), where she led CVM's efforts to implement a risk-based approach to address antimicrobial resistance, fulfilling a 2001 Congressional mandate, and was instrumental in the founding of the National Antimicrobial Resistance Monitoring System for Enteric Bacteria. Tollefson also served as Chief of Epidemiology in the Center for Food Safety and Applied Nutrition where she successfully investigated numerous outbreaks of food borne disease and served as liaison to the Centers for Disease Control and Prevention.

Will we become defenseless against bacteria? Will bacteria always find a way to infect and even kill us? The emergence of antibiotic resistant strains of bacteria poses an enormous problem around the world. Scientists believe that the overuse of antibiotics is increasing the appearance of these pathogens. In the US, increasing casualties resulting from drug resistant staphylococcus infections received wide media attention. While antibiotics only work on bacterial infections, many patients and doctors regard antibiotics as a front-line form of treating any type of infection. Antibiotics are often prescribed because the specific pathogen that is causing an illness is often difficult to determine. In some cases they are used as a preventative measure. But is this the best defense? Are there ways to beat bacteria at their own game? On September 18, 2008 at the Koshland Science Museum in Washington, D.C., Dr. Stuart Levy, professor of Molecular Biology and Microbiology at Tufts University School of Medicine and Dr. Linda Tollefson, Assistant Commissioner for Science at the U.S. Food and Drug Administration, discussed how to optimize antibiotic use and how to minimize the emergence of drug resistant pathogens. In part 1 of this 3 part video series, Dr. Levy discusses the basics of microbial pathogens, bacteria, and antibiotic resistance. And, Dr. Tollefson outlines the various types and classes of antibiotic drugs, approved uses, and current levels of effectiveness. Dr. Levy is Professor of Molecular Biology and Microbiology at Tufts University School of Medicine where he is the Director of the Center for Adaptation Genetics and Drug Resistance. He directs research on mechanisms of bacterial antibiotic resistance. Stuart Levy is also Staff Physician at the Tufts Medical Center and he also serves as the president of The International Alliance for the Prudent Use of Antibiotics. Dr. Tollefson is Assistant Commissioner for Science at the U.S. Food and Drug Administration (FDA). She previously served as Deputy Director of the Center for Veterinary Medicine (CVM), where she led CVM's efforts to implement a risk-based approach to address antimicrobial resistance, fulfilling a 2001 Congressional mandate, and was instrumental in the founding of the National Antimicrobial Resistance Monitoring System for Enteric Bacteria. Tollefson also served as Chief of Epidemiology in the Center for Food Safety and Applied Nutrition where she successfully investigated numerous outbreaks of food borne disease and served as liaison to the Centers for Disease Control and Prevention.